| Filed On | Filing |
|---|---|
| 07 Nov 2022 |
Form 4/A: Higgins John L, Director
Holds 426,731 shares of Common Stock |
| 22 Sep 2022 |
Form 4/A: Higgins John L, Director
Sold 1,000 shares ($88.1K) |
| 28 Aug 2020 |
Form 4/A: Ligand Pharmaceuticals Inc, 10% owner · Viking Therapeutics, Inc.
Sold 148,700 shares ($1.21M) |
| 24 Sep 2019 |
Form 4/A: Higgins John L, Director
Acquired 0 0.75% Convertible Senior Notes due 2023 (Open Market Purchase) |
| 03 Jul 2018 |
Form 4/A: Aryeh Jason, Director
Granted 2,474 Non-Qualified Stock Option (right to buy) |
| 03 Jul 2018 |
Form 4/A: Davis Todd C, Director
Granted 2,474 Non-Qualified Stock Option (right to buy) |
| 03 Jul 2018 |
Form 4/A: Gray Nancy Ryan, Director
Granted 2,474 Non-Qualified Stock Option (right to buy) |
| 03 Jul 2018 |
Form 4/A: Kozarich John W, Director
Granted 2,474 Non-Qualified Stock Option (right to buy) |
| 03 Jul 2018 |
Form 4/A: Lamattina John L, Director
Granted 2,474 Non-Qualified Stock Option (right to buy) |
| 03 Jul 2018 |
Form 4/A: Patel Sunil, Director
Granted 2,474 Non-Qualified Stock Option (right to buy) |
| 03 Jul 2018 |
Form 4/A: Sabba Stephen L, Director
Received 493 shares as a grant or award · Granted 2,474 Non-Qualified Stock Option (right to buy) |
| 09 Sep 2016 |
Form 4/A: Kozarich John W, Director
Received 1,666 shares by exercise or conversion ($76K) |
| 28 Apr 2015 |
Form 4/A: Sabba Stephen L, Director
Received 925 shares as a grant or award · Granted 2,754 Non-Qualified Stock Option (right to buy) |
| 18 Mar 2015 |
Form 4/A: Berkman Charles S, VP, Gen. Counsel & Secretary
Acquired 126 shares (Other Transaction) ($5.7K) |
| 25 Feb 2015 |
Form 4/A: Herman Melanie J, Director of Accounting
Acquired 103 shares (Other Transaction) ($4.66K) |
| 14 Oct 2014 |
Form 4/A: Sabba Stephen L, Director
Bought 2,000 shares ($86.2K) |
| 14 Oct 2014 |
Form 4/A: Knott David M, Director
Bought 4,000 shares ($172K) |
| 04 Jun 2013 |
Form 4/A: Higgins John L, Director
Received 6,000 shares as a grant or award · Granted 160,666 Non-Qualified Stock Option (right to buy) ($2.32M) |
| 04 Jun 2013 |
Form 4/A: Foehr Matthew W, EVP and COO
Received 16,667 shares as a grant or award · Granted 51,546 Non-Qualified Stock Option (right to buy) ($514K) |
| 19 Nov 2012 |
Form 4/A: Bvf Partners L P/IL, 10% owner and 5 others
Bought 12,515 shares ($191K) · Bought 4,076 shares ($61.1K) |
Loading...